Literature DB >> 7662492

Evaluation of Tl-201 SPECT for monitoring the treatment of pulmonary and mediastinal tumors.

R Namba1, I Narabayashi, R Matsui, K Sueyoshi, Y Nakata, K Tabuchi, T Komori.   

Abstract

Tl-201 single photon emission computed tomography (SPECT) was performed in 88 patients with pulmonary or mediastinal tumors in order to evaluate its usefulness for the detection of disease and for the assessment of the effect of treatment. We also examined mediastinal and hilar lymph node metastasis from lung cancer. Tl-201 SPECT showed abnormal accumulation on delayed images in all lung cancer patients with tumor diameters more than 12 mm. In the 14 operated lung cancer patients, mediastinal and hilar lymph node metastases with diameters of more than 15 mm were imaged, but one with a diameter of 9 mm was missed. The retention index (RI) was 27.52 +/- 31.58 in malignant tumors and -13.67 +/- 8.15 in benign tumors (p < 0.05). The RI was significantly lower after treatment than before treatment. The interval until tumor recurrence or reactivation tended to be longer in patients who showed a significant decrease in the RI after therapy. These findings suggest the usefulness of the RI as an index of therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662492     DOI: 10.1007/bf03164969

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  11 in total

1.  Single photon emission computed tomography using 201Tl chloride in pulmonary nodules: comparison with 67Ga citrate and 99mTc-labeled hexamethylpropyleneamine-oxime.

Authors:  K Itoh; H Takekawa; E Tsukamoto; K Nagao; K Nakada; S Abe; Y Kawakami; M Furudate
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

2.  201Tl SPECT in the detection of mediastinal lymph node metastases from lung cancer.

Authors:  N Tonami; K Yokoyama; J Taki; N Shuke; S Kinuya; K Nakajima; T Michigishi; T Aburano; K Hisada; Y Watanabe
Journal:  Nucl Med Commun       Date:  1991-09       Impact factor: 1.690

3.  Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer.

Authors:  N Tonami; N Shuke; K Yokoyama; H Seki; T Takayama; S Kinuya; K Nakajima; T Aburano; K Hisada; Y Watanabe
Journal:  J Nucl Med       Date:  1989-06       Impact factor: 10.057

4.  [Evaluation of SPECT with 67Ga and 201Tl in patients with primary lung cancer].

Authors:  M Tanabe; S Matsuno; K Satoh; Y Kawasaki; T Tamai; K Kojima; I Hino; Y Kawase; H Seo; N Hosokawa
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1988-11-25

5.  Evaluation of feasibility of 201TlCl scintigraphy for monitoring radiotherapeutic effects.

Authors:  K Nishigauchi
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1993-12-25

6.  Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules: usefulness of the delayed scan.

Authors:  H Ochi; H Sawa; T Fukuda; Y Inoue; H Nakajima; Y Masuda; T Okamura; Y Onoyama; S Sugano; H Ohkita; Y Tei; K Kamino; Y Kobayashi
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

7.  Effectiveness of planar image and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer.

Authors:  S Matsuno; M Tanabe; Y Kawasaki; K Satoh; A E Urrutia; M Ohkawa; M Maeda
Journal:  Eur J Nucl Med       Date:  1992

8.  Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments.

Authors:  M Salvatore; L Carratú; E Porta
Journal:  Radiology       Date:  1976-11       Impact factor: 11.105

9.  Relation between 201Tl to 67Ga uptake ratio and histological type in primary lung cancer.

Authors:  T Togawa; A Suzuki; K Kato; Y Higuchi; H Moriya; K Hoshi; K Kimura; T Kawaguchi
Journal:  Eur J Cancer Clin Oncol       Date:  1985-08

10.  Clinical evaluation of tumor imaging with 201 TI chloride.

Authors:  K Hisada; N Tonami; T Miyamae; Y Hiraki; T Yamazaki; T Maeda; M Nakajo
Journal:  Radiology       Date:  1978-11       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.